Results 1 to 10 of about 3,763 (70)
Recent Advances in Clinical Research of Prophylactic Vaccines Against Tuberculosis
Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), is one of the leading infectious causes of adult mortality worldwide. The Bacillus Calmette–Guérin (BCG) vaccine is currently the only approved vaccine for TB prevention, but its protective ...
Buyun Xu +5 more
doaj +1 more source
Background The ongoing emergence of SARS-CoV-2 variants has raised concerns about the breadth of the immune response provided by existing vaccines.Research design and methods In this study, participants aged 18–75 years with no prior COVID-19 infection ...
Yuqing Li +5 more
doaj +1 more source
Introduction The recent rollout of nirsevimab across multiple countries represents an important advancement in respiratory syncytial virus (RSV) prevention.
You Li +4 more
doaj +1 more source
Optimized Multi-Epitope Norovirus Vaccines Induce Robust Humoral and Cellular Responses in Mice
Background: Norovirus GII.4 is a major global health threat, yet no licensed vaccines exist due to the virus’s rapid evolution and high mutation rates. Objective: To rationally design and experimentally validate multi-epitope vaccine candidates against ...
Ziyan Xing +7 more
doaj +1 more source
Background While previous reports characterised global and regional variations in RSV seasonality, less is known about local variations in RSV seasonal characteristics.
Sheng Ye +6 more
doaj +1 more source
Background Oncolytic viruses are now well recognized as potential immunotherapeutic agents against cancer. However, the first FDA-approved oncolytic herpes simplex virus 1 (HSV-1), T-VEC, showed limited benefits in some patients in clinical trials. Thus,
Guosong Wang +23 more
doaj +1 more source
Background With respiratory syncytial virus vaccines recently approved for use among older adults, country-level respiratory syncytial virus (RSV) disease burden estimates are needed to inform local RSV immunisation strategy. We aimed to estimate country-
Tiantian Zhang +14 more
doaj +1 more source
Background: Pre-existing adenovirus immunity restricts the utilization of adenovirus-vectored vaccines. The current study aims to conduct a pooled analysis of eight clinical trials to evaluate the influence of pre-existing Ad5 neutralizing antibodies on ...
Wenqing Liu +6 more
doaj +1 more source
Background Vaccination is effective in preventing viral respiratory infectious diseases through protective antibodies and the gut microbiome has been proven to regulate human immunity.
Junlan Tu +9 more
doaj +1 more source
Pulmonary cryptococcosis is a common complication in immunocompromised patients. In a mouse model of pulmonary cryptococcosis, Cryptococcus neoformans induces a type 2 immune response that is detrimental to host protection. Long non-coding RNAs (lncRNAs)
Chen Yang +9 more
doaj +1 more source

